Related Experiment Video
Updated: Jun 14, 2026

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
Disaccharide derived from chondroitin sulfate A suppressed CpG-induced IL-6 secretion in macrophage-like J774.1 cells
Miao Jin1, Taku Iwamoto, Kiyoshi Yamada
1Department of Applied Biological Chemistry, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan. jinmiaollh@hotmail.com
Abstract:
Interleukin (IL)-6 secretion from macrophage cells is known to be induced by toll-like receptor (TLR) 9 ligands, CpG (microbial DNA sequences containing unmethylated CpG dinucleotides). We have found, using macrophage-like J774.1 cells, that this induction was dramatically suppressed by a disaccharide derived from chondroitin sulfate A (Di-4S), but not by chondroitin sulfate A (CS-A) itself. The suppression of IL-6 secretion by Di-4S occurred at protein and mRNA expression levels. Di-4S inhibited the degradation of interleukin-1 receptor-associated kinase 1 (IRAK1) in the signaling pathway mediated by myeloid differentiation primary response gene (88) (MyD88) when stimulated by TLR9 activation. In addition to suppressing IRAK1 activation, interference with CpG-TLR9 interaction by Di-4S is also suggested to be one of the mechanisms. Oligosaccharides derived from chondroitin sulfates would be effective suppressing agents for the TLR9-mediated inflammation reaction.
Insights
A chondroitin sulfate derivative (Di-4S) effectively suppresses toll-like receptor 9 (TLR9)-induced interleukin-6 (IL-6) secretion from macrophages. This disaccharide inhibits key signaling proteins, offering potential for managing TLR9-mediated inflammation.
Area of Science:
- Immunology
- Molecular Biology
- Biochemistry
Background:
- Toll-like receptor 9 (TLR9) ligands, like CpG, activate macrophages to secrete inflammatory cytokines such as interleukin-6 (IL-6).
- This TLR9-mediated inflammatory response is crucial in innate immunity but can contribute to autoimmune diseases.
Purpose of the Study:
- To investigate the effect of chondroitin sulfate derivatives on TLR9-induced IL-6 secretion in macrophages.
- To elucidate the molecular mechanisms underlying the observed suppression of IL-6.
Main Methods:
- Utilized macrophage-like J774.1 cell lines.
- Stimulated cells with CpG to activate TLR9.
- Administered chondroitin sulfate A (CS-A) and its derived disaccharide (Di-4S).
- Measured IL-6 secretion at protein and mRNA levels.
- Assessed the expression and degradation of signaling molecules, including IRAK1 and MyD88.
Main Results:
- Chondroitin sulfate A (CS-A) did not suppress IL-6 secretion.
- A specific disaccharide derived from CS-A (Di-4S) significantly suppressed both IL-6 protein and mRNA expression.
- Di-4S inhibited the degradation of interleukin-1 receptor-associated kinase 1 (IRAK1) in the MyD88-dependent TLR9 signaling pathway.
- Di-4S may also interfere with the direct interaction between CpG and TLR9.
Conclusions:
- Oligosaccharides derived from chondroitin sulfates, particularly Di-4S, are potent suppressors of TLR9-mediated IL-6 secretion.
- Di-4S acts by stabilizing IRAK1 and potentially disrupting CpG-TLR9 binding.
- These findings suggest that chondroitin sulfate-derived oligosaccharides could be developed as therapeutic agents to control TLR9-driven inflammatory conditions.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
The JAK-STAT Signaling Pathway
Differentiation of Common Myeloid Progenitor Cells
Glycosaminoglycans
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
